trending Market Intelligence /marketintelligence/en/news-insights/trending/POfpWirBqRDjSO6dWVwxew2 content esgSubNav
In This List

Omnicom Health Group to buy BioPharm Communications

451 Research Podcast

Next in Tech | Episode 42: AI/ML Infrastructure

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Video

S&P Capital IQ Pro | Powered by Expert Insights

451 Research Podcast

Next in Tech | Episode 41: IoT's Role in Energy and Utilities


Omnicom Health Group to buy BioPharm Communications

Omnicom Health Group agreed to buy BioPharm Communications,an agency that specializes in creating multichannel marketing programstargeting physicians and health care practitioners for its pharmaceutical andbiotechnology clients.

Financial terms of the deal were not disclosed. Thetransaction is expected to close in the second quarter, subject to regulatoryapproval, the company said May 5. Jeff Persinger and Daniel Egeland,co-founders of BioPharm, will continue to lead the company as president andCEO, and executive vice president and chief sales and marketing officer,respectively. Certain other executives, including Chief StrategyOfficer Norm Phillips, COO Steve Carickhoff, and Head of Analytics LarsNordmann, will retain their current positions.

Omnicom Health Group is part of the DAS Group of Cos., adivision of Omnicom GroupInc.